(Q34018007)

30 July 2017

1 reference

title

Therapeutic interventions in HIV infection - a critical view (English)

1 reference

30 July 2017

Darbyshire J

1

1 reference

30 July 2017

publication date

1 July 2000

1 reference

Tropical Medicine and International Health

30 July 2017

published in

1 reference

30 July 2017

volume

5

1 reference

30 July 2017

issue

7

1 reference

30 July 2017

page(s)

A26-31

1 reference

A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00597.X

Antiretroviral therapy for patients with HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00597.X

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00597.X

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00597.X

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00597.X

Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00597.X

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00597.X

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00597.X

Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00597.X

Toward HIV eradication or remission: the tasks ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00597.X

"Buffalo hump" in men with HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00597.X

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00597.X

A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00597.X

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00597.X

A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1-infected patients. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00597.X

Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00597.X

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00597.X

10.1046/J.1365-3156.2000.00597.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference